Results 191 to 200 of about 10,310,741 (229)
Some of the next articles are maybe not open access.

How I Diagnose Rosai-Dorfman Disease.

American Journal of Clinical Pathology, 2023
OBJECTIVES Rosai-Dorfman disease (RDD) is one of 3 major types of histiocytosis, along with Erdheim-Chester disease and Langerhans cell histiocytosis.
A. Ravindran, K. Rech
semanticscholar   +1 more source

Cyclin D1 expression in Rosai-Dorfman disease: A near constant finding that is not invariably associated with MAPK/ERK pathway activation.

Human Pathology, 2022
Activating mutations in the MAPK/ERK pathway have been shown in nearly half of cases of Rosai-Dorfman disease (RDD). Cyclin D1, a key cell cycle regulator, constitutes a major downstream target of the MAPK/ERK pathway.
S. Garcés   +16 more
semanticscholar   +1 more source

Radiological features of Rosai-Dorfman disease: case series and review of the literature.

Clinical Radiology, 2022
AIM To improve the accuracy of diagnosis of Rosai-Dorfman disease (RDD) by summarising the computed tomography (CT) and magnetic resonance imaging (MRI) characteristics.
H. Li   +7 more
semanticscholar   +1 more source

Rosai-Dorfman Disease of the Breast: A Clinicoradiologic and Pathologic Study.

Human Pathology, 2023
Rosai-Dorfman disease (RDD) is an uncommon histiocytic disorder typically involving lymph nodes and less frequently extranodal tissues. RDD involving the breast is rare and may clinically and radiologically mimic neoplastic and non-neoplastic disorders ...
Qun Wang   +4 more
semanticscholar   +1 more source

The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease.

Mayo Clinic proceedings, 2019
Histiocytic neoplasms, a rare and heterogeneous group of disorders, primarily include Erdheim-Chester disease, Langerhans cell histiocytosis, and Rosai-Dorfman disease.
G. Goyal   +13 more
semanticscholar   +1 more source

Rosai-Dorfman Disease Displays a Unique Monocyte-Macrophage Phenotype Characterized by Expression of OCT2

American Journal of Surgical Pathology, 2020
Rosai-Dorfman disease (RDD) is a rare histiocytosis with heterogenous clinical features. In this study, we characterized the histologic and phenotypic features in 33 RDD patients to better define the pathologic diagnosis.
A. Ravindran, G. Goyal, R. Go, K. Rech
semanticscholar   +1 more source

Fractional laser combined with 5-Aminolevulinic acid photodynamic therapy for the treatment of Cutaneous Rosai-Dorfman Disease: a case report.

Photodiagnosis and Photodynamic Therapy, 2023
Rosai-Dorfman disease(RDD) is a rare benign histiocytic proliferative disorder. Cutaneous Rosai-Dorfman disease(CRDD)is a rare variant of RDD with lesions localized to the skin.
Huan Wang   +6 more
semanticscholar   +1 more source

Rosai-Dorfman Disease Mimicking Metastasis to the Spleen From Breast Cancer.

Clinical Nuclear Medicine
Rosai-Dorfman disease is a non-Langerhans cell histiocytosis with ubiquitous distribution. Although more common in lymph nodes, it has been described in many organ systems.
Zamaan Hooda   +4 more
semanticscholar   +1 more source

Primary Rosai-Dorfman disease of the thymus and lung: A clinicopathological and immunohistochemical study of three cases.

Pathology, Research and Practice, 2022
Three cases of primary Rosai-Dorfman disease of the thymus and lung are presented. The patients are 3 men between the ages of 42 and 47 years who presented with non-specific symptoms including cough, chest pain, and shortness of breath.
D. Oramas, C. Moran
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy